Manorama Industries Ltd

- Currently, Manorama Industries Limited is funding its projects through internal accruals. - There is no immediate plan for external financing as of now. - Management will provide updates if the company targets any external financing in the future. - The company maintains a strong financial position including a fixed deposit of around INR 130 crores. - Capex of approximately INR 460 crores is planned over the next two to three years and will be funded internally at present. - The company is focused on disciplined capital allocation and maintaining financial strength.

- Manorama Industries has an ongoing capex plan of around INR 460 crores spread over the next 2-3 years, funded primarily through internal accruals with potential external financing options being evaluated (including QIP). - Key projects include forward integration with a CBA plant, solvent fractionation 3 plant (capacity 75,000 tons), and refinery plant (90,000 tons per annum); targeted commissioning by FY 28. - Burkina Faso backward integration project with capex of ~INR 120 crores aims to reduce logistics costs and improve yield, enhancing margins. - Current debottlenecking increased capacity from 47,500 to 52,000 tons with minimal cost (~INR 8-10 crores). - Strategic goal: To strengthen global footprint and specialty fats/butter market position with disciplined capital allocation focused on high-return investments. - Management expects 6x asset turn on forward integration projects, driving growth and margin expansion in the medium term.

- For FY 2027, Manorama Industries targets strong volume-led growth of around 20%-30%, with an additional 5%-10% price realization benefit. - The company aims to utilize around 85%-90% of its increased capacity of 52,000 metric tons in FY 2027. - Debottlenecking efforts have increased capacity from 40,000 to 52,000 tons, supporting volume growth. - The value-added product mix is being upgraded, with CBE contributing ~30% to revenues, up from 10% two years ago. - Long-term growth is expected beyond FY 2027, supported by ongoing capex of INR 460 crores planned over 2-3 years. - Management is confident of sustaining EBITDA margins of 25%-27% alongside growth. - Export diversification and global presence expansion are additional growth drivers.

- Company targets strong volume growth of 20%-30% plus, with price hikes of 5%-10%, especially in FY27. - Utilization of solvent fractionation capacity expected to reach 85%-90% on 52,000 tons capacity in FY27. - Long-term revenue target exceeds INR 3,500 crores by FY30, supported by ongoing capex plans including 75,000 tons solvent fractionation capacity and backward integration. - Margin guidance maintained sustainably at 25%-27% EBITDA margin yearly. - Operating cash flow strong with INR 260 crores generated in FY26; management confident of sustaining margins and cash conversion cycles. - Expansion into global markets with increasing value-added product mix expected to sustain revenue growth. - Capex of INR 460 crores planned over 2-3 years aimed to scale operations efficiently. - Overall growth expected to be volume-led with price realization benefits, projecting 25%-30% growth rates in near term.

The provided pages of the Manorama Industries Limited document do not contain specific information regarding the current or expected order book or pending orders. The discussion primarily covers topics such as: - Capacity utilization and debottlenecking updates - Margin guidance and sustainable EBITDA margins (25%-27%) - Capex plans and funding strategies - Raw material sourcing and supply chain - Impact of geopolitical tensions on business - Subsidiary performance and associated costs No explicit data or commentary on order book status or pending orders is mentioned in these excerpts. If you need details on the order book or pending orders, please provide the relevant pages or sections.